ArticleScientific reports2026
Machine learning improves prediction of pulmonary thromboembolism and reduces unnecessary computed tomography scans in the emergency department.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The diagnosis of pulmonary thromboembolism (PTE) remains challenging due to its nonspecific clinical signs and symptoms. This study aimed to develop a machine learning (ML) model to predict PTE in emergency department patients. We retrospectively analyzed 2,525 emergency department patients suspected of PTE who underwent computed tomography pulmonary angiography (CTPA) within 7 days after elevated D-dimer levels (≥ 0.5 µg/ml) at a tertiary hospital, between January 2012 and December 2021. Clinical and laboratory data were split into training (n = 2025) and test (n = 500) sets. Six ML models-XGBoost, random forest, logistic regression, elastic net regression, support vector machine, and feed-forward neural network-were compared with the revised Geneva score using the area under the receiver operating characteristic curve (AUC). Variable importance was assessed using permutation methods. Of the 2,525 patients, 573 (22.7%) were diagnosed with PTE. XGBoost achieved the highest AUC of 0.814 (95% confidence interval [CI]: 0.759-0.862). All ML models outperformed the revised Geneva score, which had an AUC of 0.622 (95% CI: 0.563-0.675). D-dimer and activated partial thromboplastin time were the most important predictors across all ML models. At sensitivities of 100%, 95%, and 90%, the XGBoost model could reduce the number of CTPA scans by 3.0%, 14.8%, and 33.2%, respectively (all p < 0.001). These findings suggest that ML models, particularly XGBoost, can improve PTE risk prediction compared to the revised Geneva score and may help reduce unnecessary CTPA imaging in the emergency department.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.